APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Sevoflurane Anaesthetic Agent

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Inhalation Sevoflurane Anaesthetic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026180 pages

Choose your research edition.

Industry ResearchInhalation Sevoflurane Anaesthetic Agent Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Sevoflurane Anaesthetic Agent Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Inhalation Sevoflurane Anaesthetic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Sevoflurane Anaesthetic Agent Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Sevoflurane Anaesthetic Agent Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Inhalation Sevoflurane Anaesthetic Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Inhalation Sevoflurane Anaesthetic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalation Sevoflurane Anaesthetic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation Sevoflurane Anaesthetic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Inhalation Sevoflurane Anaesthetic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhalation Sevoflurane Anaesthetic Agent include Maruishi, Piramal, PT Novell Pharmaceutical, Viatris, AbbVie and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalation Sevoflurane Anaesthetic Agent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalation Sevoflurane Anaesthetic Agent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalation Sevoflurane Anaesthetic Agent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalation Sevoflurane Anaesthetic Agent market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalation Sevoflurane Anaesthetic Agent Segment by Company

Maruishi

Piramal

PT Novell Pharmaceutical

Viatris

AbbVie

Baxter

Inhalation Sevoflurane Anaesthetic Agent Segment by Type

250ml/Bottle

120ml/Bottle

Other

Inhalation Sevoflurane Anaesthetic Agent Segment by Application

Hospital

Clinics

Other

Inhalation Sevoflurane Anaesthetic Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Sevoflurane Anaesthetic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Sevoflurane Anaesthetic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Sevoflurane Anaesthetic Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalation Sevoflurane Anaesthetic Agent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhalation Sevoflurane Anaesthetic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Inhalation Sevoflurane Anaesthetic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Inhalation Sevoflurane Anaesthetic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Inhalation Sevoflurane Anaesthetic Agent Industry Trends Table 2. Inhalation Sevoflurane Anaesthetic Agent Industry Drivers Table 3. Inhalation Sevoflurane Anaesthetic Agent Industry Opportunities and Challenges Table 4. Inhalation Sevoflurane Anaesthetic Agent Industry Restraints Table 5. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Manufacturers Table 9. Global Inhalation Sevoflurane Anaesthetic Agent Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Inhalation Sevoflurane Anaesthetic Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Inhalation Sevoflurane Anaesthetic Agent Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers, Product Type & Application Table 13. Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalation Sevoflurane Anaesthetic Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 250ml/Bottle Table 17. Major Manufacturers of 120ml/Bottle Table 18. Major Manufacturers of Other Table 19. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 21. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2027-2032) & (K Units) Table 22. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2021-2026) Table 23. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2027-2032) Table 24. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2026) & (K Units) Table 26. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2027-2032) & (K Units) Table 27. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2021-2026) Table 28. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Other Table 32. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 34. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2027-2032) & (K Units) Table 35. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2021-2026) Table 36. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2027-2032) Table 37. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2026) & (K Units) Table 39. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2027-2032) & (K Units) Table 40. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2021-2026) Table 41. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2027-2032) Table 42. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2021-2026) & (K Units) Table 44. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2021-2026) Table 45. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 49. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2027-2032) & (K Units) Table 50. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 52. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2027-2032) & (K Units) Table 59. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2021-2026) Table 63. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2027-2032) Table 64. Maruishi Company Information Table 65. Maruishi Business Overview Table 66. Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 68. Maruishi Recent Development Table 69. Piramal Company Information Table 70. Piramal Business Overview Table 71. Piramal Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Piramal Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 73. Piramal Recent Development Table 74. PT Novell Pharmaceutical Company Information Table 75. PT Novell Pharmaceutical Business Overview Table 76. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 78. PT Novell Pharmaceutical Recent Development Table 79. Viatris Company Information Table 80. Viatris Business Overview Table 81. Viatris Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Viatris Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 83. Viatris Recent Development Table 84. AbbVie Company Information Table 85. AbbVie Business Overview Table 86. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 88. AbbVie Recent Development Table 89. Baxter Company Information Table 90. Baxter Business Overview Table 91. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 93. Baxter Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Inhalation Sevoflurane Anaesthetic Agent Distributors List Table 97. Inhalation Sevoflurane Anaesthetic Agent Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Inhalation Sevoflurane Anaesthetic Agent Product Image Figure 2. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhalation Sevoflurane Anaesthetic Agent Sales (2021-2032) & (K Units) Figure 5. Global Inhalation Sevoflurane Anaesthetic Agent Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Inhalation Sevoflurane Anaesthetic Agent Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 250ml/Bottle Image Figure 9. 120ml/Bottle Image Figure 10. Other Image Figure 11. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2021-2032) Figure 14. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinics Image Figure 19. Other Image Figure 20. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2021-2032) Figure 23. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2021-2032) Figure 26. North America Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2021-2032) Figure 28. U.S. Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2021-2032) Figure 33. Germany Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2021-2032) Figure 40. China Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2021-2032) Figure 48. Brazil Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Inhalation Sevoflurane Anaesthetic Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Figure 59. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Figure 61. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Inhalation Sevoflurane Anaesthetic Agent Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Inhalation Sevoflurane Anaesthetic Agent Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 250ml/Bottle
  • 120ml/Bottle
  • Other
Applications
  • Hospital
  • Clinics
  • Other
Companies covered
  • Maruishi
  • Piramal
  • PT Novell Pharmaceutical
  • Viatris
  • AbbVie
  • Baxter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Inhalation Sevoflurane Anaesthetic Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Inhalation Sevoflurane Anaesthetic Agent Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Inhalation Sevoflurane Anaesthetic Agent Market Dynamics
  1. 2.1 Inhalation Sevoflurane Anaesthetic Agent Industry Trends
  2. 2.2 Inhalation Sevoflurane Anaesthetic Agent Industry Drivers
  3. 2.3 Inhalation Sevoflurane Anaesthetic Agent Industry Opportunities and Challenges
  4. 2.4 Inhalation Sevoflurane Anaesthetic Agent Industry Restraints
3 Inhalation Sevoflurane Anaesthetic Agent Market by Manufacturers
  1. 3.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Manufacturers (2021-2026)
  3. 3.3 Global Inhalation Sevoflurane Anaesthetic Agent Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Inhalation Sevoflurane Anaesthetic Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhalation Sevoflurane Anaesthetic Agent Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers, Product Type & Application
  7. 3.7 Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhalation Sevoflurane Anaesthetic Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhalation Sevoflurane Anaesthetic Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhalation Sevoflurane Anaesthetic Agent Tier 1, Tier 2, and Tier 3
4 Inhalation Sevoflurane Anaesthetic Agent Market by Type
  1. 4.1 Inhalation Sevoflurane Anaesthetic Agent Type Introduction
  2. 4.1.1 250ml/Bottle
  3. 4.1.2 120ml/Bottle
  4. 4.1.3 Other
  5. 4.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type
  6. 4.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2032)
  8. 4.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2021-2032)
  9. 4.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type
  10. 4.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2032)
  12. 4.3.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2021-2032)
5 Inhalation Sevoflurane Anaesthetic Agent Market by Application
  1. 5.1 Inhalation Sevoflurane Anaesthetic Agent Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application
  6. 5.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2032)
  8. 5.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2021-2032)
  9. 5.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application
  10. 5.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2032)
  12. 5.3.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2021-2032)
6 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region
  1. 6.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2021-2026)
  4. 6.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region
  1. 7.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region
  2. 7.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2021-2026)
  4. 7.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2027-2032)
  5. 7.1.4 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032)
  8. 7.2.2 North America Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032)
  11. 7.3.2 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Maruishi
  2. 8.1.1 Maruishi Company Information
  3. 8.1.2 Maruishi Business Overview
  4. 8.1.3 Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  6. 8.1.5 Maruishi Recent Developments
  7. 8.2 Piramal
  8. 8.2.1 Piramal Company Information
  9. 8.2.2 Piramal Business Overview
  10. 8.2.3 Piramal Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Piramal Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  12. 8.2.5 Piramal Recent Developments
  13. 8.3 PT Novell Pharmaceutical
  14. 8.3.1 PT Novell Pharmaceutical Company Information
  15. 8.3.2 PT Novell Pharmaceutical Business Overview
  16. 8.3.3 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  18. 8.3.5 PT Novell Pharmaceutical Recent Developments
  19. 8.4 Viatris
  20. 8.4.1 Viatris Company Information
  21. 8.4.2 Viatris Business Overview
  22. 8.4.3 Viatris Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Viatris Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  24. 8.4.5 Viatris Recent Developments
  25. 8.5 AbbVie
  26. 8.5.1 AbbVie Company Information
  27. 8.5.2 AbbVie Business Overview
  28. 8.5.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  30. 8.5.5 AbbVie Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  36. 8.6.5 Baxter Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalation Sevoflurane Anaesthetic Agent Value Chain Analysis
  2. 9.1.1 Inhalation Sevoflurane Anaesthetic Agent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalation Sevoflurane Anaesthetic Agent Production Mode & Process
  6. 9.2 Inhalation Sevoflurane Anaesthetic Agent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalation Sevoflurane Anaesthetic Agent Distributors
  9. 9.2.3 Inhalation Sevoflurane Anaesthetic Agent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst